Fundamental limit of alpha-synuclein pathology in gastrointestinal biopsy as a pathologic biomarker of Parkinson’s disease: Comparison with surgical specimens
- 1 November 2017
- journal article
- research article
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 44, 73-78
Abstract
No abstract availableKeywords
Funding Information
- Seoul National University Hospital (0420170460)
- Samil Pharmaceuticals (0620151450)
- National Research Foundation (NRF-2016 H1A2A 1907713)
This publication has 26 references indexed in Scilit:
- In vivo gastric detection of α‐synuclein inclusions in Parkinson's diseaseMovement Disorders, 2014
- Multiple organ involvement by alpha‐synuclein pathology in Lewy body disordersMovement Disorders, 2014
- Enteric alpha‐synuclein expression is increased in Parkinson's disease but not Alzheimer's diseaseMovement Disorders, 2013
- Parkinson’s disease is not associated with gastrointestinal myenteric ganglion neuron lossActa Neuropathologica, 2012
- A comparison between colonic submucosa and mucosa to detect Lewy pathology in Parkinson’s diseaseNeurogastroenterology & Motility, 2012
- A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson's diseaseNeurobiology of Disease, 2012
- Alpha‐synuclein in colonic submucosa in early untreated Parkinson's diseaseMovement Disorders, 2011
- Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disordersActa Neuropathologica, 2010
- Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathologyNeuroscience Letters, 2006
- Staging of brain pathology related to sporadic Parkinson’s diseaseNeurobiology of Aging, 2003